Francesca Bianchini

15PUBLICATIONS
51CO-AUTHORS
Medical infection agents (incl. prions)Molecular targetsPredictive and prognostic markersCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Sep 15, 2026
Computational Repurposing of FDA-Approved Drugs as Candidate MMP2 Inhibitors with Putative MMP3 Cross-Activity.

|Aug 02, 2025
The unexplored mechanism of antitumoral effect of pirfenidone in melanoma cells.

Melissa Marchese, Gilda La Regina, Rachele Amato

|Jan 21, 2023
Nintedanib-αVβ6 Integrin Ligand Conjugates Reduce TGFβ-Induced EMT in Human Non-Small Cell Lung Cancer.

Elena Andreucci, Kelly Bugatti, Silvia Peppicelli

|Dec 11, 2022
Extracellular Acidosis Differentially Regulates Estrogen Receptor β-Dependent EMT Reprogramming in Female and Male Melanoma Cells.

Silvia Peppicelli, Jessica Ruzzolini, Matteo Lulli

|Oct 27, 2022
miR-214-Enriched Extracellular Vesicles Released by Acid-Adapted Melanoma Cells Promote Inflammatory Macrophage-Dependent Tumor Trans-Endothelial Migration.

Elena Andreucci, Jessica Ruzzolini, Francesca Bianchini

|Sep 23, 2022
An Oleocanthal-Enriched EVO Oil Extract Induces the ROS Production in Gastric Cancer Cells and Potentiates the Effect of Chemotherapy.

Sara Peri, Jessica Ruzzolini, Silvia Urciuoli

Pageof 3

Frequent Collaborators

6 joint publications

Lido Calorini

6 joint publications

Silvia Peppicelli

6 joint publications

Chiara Nediani

5 joint publications

Elena Andreucci